z-logo
Premium
Nephrotic syndrome developing in association with thymoma and myasthenia gravis
Author(s) -
O'Riordan J. I.,
Brenner R.,
Howard R. S.,
Miller D. H.
Publication year - 1997
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/j.1468-1331.1997.tb00372.x
Subject(s) - myasthenia gravis , medicine , thymoma , thymectomy , azathioprine , nephrotic syndrome , pyridostigmine , prednisolone , gastroenterology , immunosuppression , biopsy , immunology , disease
Three patients with thymoma associated myasthenia gravis complicated by the nephrotic syndrome are described. There were two male and one female patients with a mean age at presentation of 55.6 years (27–75). In all cases anti striated‐muscle and acetylcholine‐receptor antibodies were present. Thymectomy was performed 1.4 years (1–3) after diagnosis of myasthenia gravis; histology revealed invasive mixed lymphocytic/epithelial (1), invasive epithelial (1) and non‐invasive lymphocytic/epithelial (1) cell thymoma. All patients were receiving pyridostigmine, prednisolone and azathioprine at the time nephrotic syndrome developed (a mean of 2 years after thymectomy). Renal biopsy demonstrated a minimal change nephropathy alone in all three. Remission following increased steroids occurred in two despite continuing azathioprine. Myasthenic symptoms remained stable throughout. The third patient died 3 weeks after onset of nephrotic syndrome. The cause of the nephrotic syndrome is uncertain, but an immune mechanism, possibly in genetically predisposed individuals, is perhaps most likely.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here